Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3390/livers3030023
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2023
- Urheber
- DOI
-
10.18154/RWTH-2023-12025
- URN
-
urn:nbn:de:101:1-2406140205154.573216197417
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weiskirchen, Ralf
- Sauerbruch, Tilman
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2023
Ähnliche Objekte (12)
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
CCNs and other extracellular matrix proteins: an introduction to the special issue
CCNs and other extracellular matrix proteins: an introduction to the special issue
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
CCNs and other extracellular matrix proteins: an introduction to the special issue
CCNs and other extracellular matrix proteins: an introduction to the special issue
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
CCNs and other extracellular matrix proteins: an introduction to the special issue
CCNs and other extracellular matrix proteins: an introduction to the special issue
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis